Adduct formation on DNA and haemoglobin in mice intraperitoneally administered with styrene

被引:56
作者
Pauwels, W
Vodiceka, P
Severi, M
Plna, K
Veulemans, H
Hemminki, K
机构
[1] ACAD SCI CZECH REPUBL, INST EXPT MED, DEPT DEV GENOTOXICOL, PRAGUE 14220 4, CZECH REPUBLIC
[2] KATHOLIEKE UNIV LEUVEN, LAB OCCUPAT HYG & TOXICOL, B-3001 LOUVAIN, BELGIUM
[3] KAROLINSKA INST, NOVUM, CNT, HUDDINGE, SWEDEN
关键词
D O I
10.1093/carcin/17.12.2673
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Styrene-specific N-7- and O-6-guanine DNA adducts and N-terminal valine adducts were determined in mice tissues after the intraperitoneal administration of styrene, Blood, liver, lungs and spleen were collected 3 h after administration of various doses (from O to 4.35 mmol/kg b.w.) of styrene, DNA adducts were analysed by the modified P-32-postlabelling assay and N-terminal valine adducts were detected by GC-MS according to the modified Edman degradation technique, In the dose-range studied, for all adducts a clear dose-response relationship was observed, 7-Alkylguanines and O-6-styrene guanine adducts were most abundant in lungs, similar to 30% more than in liver and spleen. In all analysed tissues 7-alkylguanines were more abundant than O-6-styrene guanine adducts, We found a considerably lower rate of N-terminal valine adduct formation as compared with both DNA adducts, The ratio between 7-alkylguanines and O-6-guanine adducts was 1.9, 1.6 and 7.8 in liver, lung and spleen, respectively, In vitro determination of both DNA adducts by P-32-postlabelling resulted also in a lower ratio than that reported earlier using an HPLC analysis, All correlation's between dose, haemoglobin and DNA adducts were very high and significant, However, at the highest injected doses the adduct formation showed a levelling off, To explain this phenomenon a model simulation was performed revealing that 3 h after the injection of the higher doses styrene was not completely converted into styrene-7, 8-oxide.
引用
收藏
页码:2673 / 2680
页数:8
相关论文
共 41 条
[1]  
BASTLOVA T, 1996, IN PRESS MUTAGENESIS
[2]   DNA-ADDUCTS OF THE UBIQUITOUS ENVIRONMENTAL CONTAMINANT CYCLOPENTA[CD]PYRENE [J].
BEACH, AC ;
GUPTA, RC .
CARCINOGENESIS, 1994, 15 (05) :1065-1072
[3]  
BELVEDERE G, 1983, EXTRAHEPATIC DRUG ME, P193
[4]   INVESTIGATION OF THE COVALENT BINDING OF STYRENE-7,8-OXIDE TO DNA IN RAT AND MOUSE [J].
CANTOREGGI, S ;
LUTZ, WK .
CARCINOGENESIS, 1992, 13 (02) :193-197
[5]   COVALENT BINDING OF STYRENE TO DNA IN RAT AND MOUSE [J].
CANTOREGGI, S ;
LUTZ, WK .
CARCINOGENESIS, 1993, 14 (03) :355-360
[6]   A PHYSIOLOGICAL PHARMACOKINETIC MODEL FOR STYRENE AND STYRENE-7,8-OXIDE IN MOUSE, RAT AND MAN [J].
CSANADY, GA ;
MENDRALA, AL ;
NOLAN, RJ ;
FILSER, JG .
ARCHIVES OF TOXICOLOGY, 1994, 68 (03) :143-157
[7]  
DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387
[8]  
EHRENBERG L, 1980, Teratogenesis Carcinogenesis and Mutagenesis, V1, P105
[9]   STYRENE - FROM CHARACTERIZATION OF DNA-ADDUCTS TO APPLICATION IN STYRENE-EXPOSED LAMINATION WORKERS [J].
HEMMINKI, K ;
VODICKA, P .
TOXICOLOGY LETTERS, 1995, 77 (1-3) :153-161
[10]   SYNTHESIS AND STABILITY OF 2'-DEOXYGUANOSINE 3'-MONOPHOSPHATE ADDUCTS OF DIMETHYL SULFATE, ETHYLENE-OXIDE AND STYRENE OXIDE [J].
HEMMINKI, K ;
ALHONENRAATESALMI, A ;
KOIVISTO, P ;
VODICKA, P .
CHEMICO-BIOLOGICAL INTERACTIONS, 1990, 75 (03) :281-292